Research location
North Hollywood
California, United States
Advertisement
Research activity in North Hollywood
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 70 trials and 70 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in North Hollywood
70 linked trials · page 1 of 2A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 1 site observation
RECRUITING
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)NCT06926842 · 2025-04-22 · 1 site observation
COMPLETED
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaNCT06676319 · 2024-11-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With AsthmaNCT06261957 · 2024-05-31 · 1 site observation
COMPLETED
Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareNCT06422689 · 2024-05-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityNCT06373146 · 2024-04-24 · 1 site observation
COMPLETED
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)NCT06309992 · 2024-04-02 · 1 site observation
COMPLETED
Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)NCT06045507 · 2023-11-08 · 1 site observation
COMPLETED
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskNCT05803421 · 2023-04-03 · 1 site observation
COMPLETED
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidNCT05292586 · 2022-08-31 · 1 site observation
COMPLETED
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesNCT05433584 · 2022-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Test if TEV-53275 is Effective in Relieving AsthmaNCT04847674 · 2021-05-04 · 1 site observation
TERMINATED
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)NCT04795531 · 2021-03-24 · 1 site observation
COMPLETED
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04760626 · 2021-03-01 · 1 site observation
COMPLETED
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)NCT04609904 · 2021-03-01 · 1 site observation
COMPLETED
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04460885 · 2020-11-25 · 1 site observation
COMPLETED
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic PainNCT04455633 · 2020-09-03 · 1 site observation
COMPLETED
Mylan Insulin Aspart StudyNCT03760068 · 2018-11-07 · 1 site observation
COMPLETED
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 DiabetesNCT03560271 · 2018-06-18 · 1 site observation
COMPLETED
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant AsthmaNCT03358147 · 2017-12-13 · 1 site observation
COMPLETED
Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsNCT03259789 · 2017-11-28 · 1 site observation
COMPLETED
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic SubjectsNCT03084718 · 2017-07-28 · 1 site observation
COMPLETED
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaNCT03118739 · 2017-05-18 · 1 site observation
COMPLETED
A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DMNCT03090464 · 2017-05-08 · 1 site observation
COMPLETED
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on MetforminNCT03060980 · 2017-03-03 · 1 site observation
TERMINATED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyNCT02906930 · 2016-09-20 · 1 site observation
COMPLETED
A Study of LGD-6972 in Patients With Type 2 Diabetes MellitusNCT02851849 · 2016-09-01 · 1 site observation
COMPLETED
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 DiabetesNCT02762370 · 2016-04-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of LHW090 in Resistant Hypertension PatientsNCT02515331 · 2015-11-04 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDNCT02547935 · 2015-09-21 · 1 site observation
COMPLETED
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DMNCT02526524 · 2015-09-01 · 1 site observation
COMPLETED
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusNCT02496000 · 2015-07-27 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected SubjectsNCT02431247 · 2015-07-06 · 1 site observation
COMPLETED
A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)NCT02451137 · 2015-06-16 · 1 site observation
COMPLETED
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)NCT02414854 · 2015-04-27 · 1 site observation
COMPLETED
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.NCT02288273 · 2014-12-01 · 1 site observation
COMPLETED
Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)NCT02134028 · 2014-08-05 · 1 site observation
COMPLETED
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesNCT02030600 · 2014-01-06 · 1 site observation
COMPLETED
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsNCT01959529 · 2013-10-29 · 1 site observation
COMPLETED
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Fasiglifam 25 mg BID vs 50 mg QDNCT01982253 · 2013-10-01 · 1 site observation
TERMINATED
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 DiabetesNCT01831765 · 2013-08-26 · 1 site observation
COMPLETED
Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 AgonistNCT01914757 · 2013-08-01 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)NCT01854658 · 2013-07-01 · 1 site observation
COMPLETED
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator ReversibilityNCT01902290 · 2013-05-22 · 1 site observation
TERMINATED
TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 DiabetesNCT01829464 · 2013-05-01 · 1 site observation
TERMINATED
Study of Safety of Foradil in Patients With Persistent AsthmaNCT01845025 · 2013-05-01 · 1 site observation
TERMINATED
Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 DiabetesNCT01829477 · 2013-04-01 · 1 site observation
TERMINATED
Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney DiseaseNCT01752985 · 2013-03-18 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.